Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021

Rhea-AI Summary

On July 19, 2021, Anika Therapeutics (NASDAQ: ANIK) announced plans to issue its Q2 2021 financial results after market close on August 5, 2021. An investor conference call is scheduled for the same day at 5:00 p.m. ET to discuss the results and business highlights. The call will be accessible via toll-free and international numbers, and will also be available through a live audio webcast on Anika's Investor Relations website. Anika is focused on early intervention in orthopedics, providing minimally invasive solutions for joint preservation.

Positive

• Scheduled earnings call on August 5, 2021, showing commitment to investor communication.

Negative

• None.

BEDFORD, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its second quarter 2021 financial results after the close of the market on Thursday, August 5, 2021 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.

The conference call can be accessed by dialing 1-866-269-4262 (toll-free domestic) or 1-856-344-9206 (international) and providing the conference ID number 2579568. A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. For more information, please visit www.anika.com.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Executive Director, Investor Relations and Corporate Communications
investorrelations@anika.com

FAQ

When will Anika Therapeutics release its Q2 2021 financial results?

Anika Therapeutics will release its Q2 2021 financial results after market close on August 5, 2021.

What time is the Anika Therapeutics investor conference call?

The investor conference call for Anika Therapeutics is scheduled for 5:00 p.m. ET on August 5, 2021.

How can I access the Anika Therapeutics conference call?

You can access the Anika Therapeutics conference call by dialing 1-866-269-4262 (toll-free) or 1-856-344-9206 (international) and using conference ID 2579568.

Where can I find the live audio webcast for Anika's earnings call?

The live audio webcast for Anika's earnings call can be found in the Investor Relations section of Anika's website.

What is Anika Therapeutics focused on?

Anika Therapeutics focuses on joint preservation in early intervention orthopedics, developing minimally invasive products for osteoarthritis pain management and other orthopedic solutions.